Navigation Links
Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
Date:5/14/2012

PARIS, May 14, 2012 /PRNewswire/ --


  • Results of head-to-head study comparing two biologic drugs on a background of methotrexate for the treatment of moderate to severe rheumatoid arthritis to be presented

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the company will present 18 abstracts on abatacept at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology in Berlin, June 6-9. Among the data being presented will be results from the AMPLE study, a head-to-head phase 3 clinical trial comparing subcutaneous (SC) ORENCIA® (abatacept) to HUMIRA® (adalimumab), both in combination with methotrexate. The combination of a biologic medication and methotrexate is the most commonly prescribed treatment approach in moderate to severe RA.

AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects With Background Methotrexate) is a randomized, controlled study powered to compare the efficacy of abatacept SC versus adalimumab on a background of methotrexate in adult, biologic naïve patients with moderate to severe RA. AMPLE is an ongoing 2 year study, with primary analyses at 1 year. In addition to assessing the primary endpoint of non-inferiority between abatacept SC and adalimumab as defined by the proportion of subjects achieving the American College of Rheumatology criteria of 20 percent improvement (ACR 20) after 12 months of treatment, the trial also evaluated the following secondary endpoints: frequency of injection site reactions, radiographic non-progression as assessed using the van der Heijde modified total Sharp score (mTSS) method, safety and retention. The study also evaluated addi
'/>"/>

SOURCE Bristol-Myers Squibb
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BT Signs Multi-Year, Managed Services Contract with Bristol-Myers Squibb
2. Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound
3. Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
4. GNS Healthcare Announces Collaboration With Bristol-Myers Squibb
5. Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6
6. Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
7. Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
8. Bristol-Myers Squibb Sued for Denying Employees Overtime Pay
9. Bend Research Announces Extension of Drug-Discovery Enablement and Development Services Agreement With Bristol-Myers Squibb
10. Isis Earns $6 Million Milestone Payment From Bristol-Myers Squibb for BMS-PCSK9Rx
11. Top Bristol-Myers Squibb Executive Joins Patton Boggs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... MONMOUTH JUNCTION, N.J. , Jan. 23, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... surgery patients, announced the receipt of $385,642, net ... approved participant of the Technology Business Tax Certificate ...
(Date:1/23/2015)... LONDON and BOSTON , January ... structure-guided drug discovery and development company, is delighted to announce ... has been awarded to Miles Congreve (Vice President ... co-founder) and Malcolm Weir (Chief Executive Officer and ...
(Date:1/22/2015)... 22, 2015  BiOptix is pleased to announce the appointment ... of Chemistry and Biochemistry. Scott joins the company after previous ... Amgen throughout the course of his nearly 20 year ... is a nationally recognized thought leader in the biosensor ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
(Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
(Date:1/22/2015)... Weddingshe.com has added many trendy Champagne wedding dresses ... in the past three years. Today, the business announces a ... to the sales manager of the company, this is on ... This point can be reflected on the discounted wedding dresses ...
(Date:1/22/2015)... 2015 Four years since the release of their ... with the marriage of Avasa & Matthew Love – the duo ... scheduled for release through White Swan Records on February 24, 2015. ... a sacred path available to all of us to walk out ...
(Date:1/22/2015)... IPSWICH, Mass. (PRWEB) January 22, 2015 ... Association (AMA) are expanding their relationship in an effort ... journals around the world. While EBSCO has long made AMA ... as a sales agent for The JAMA Network. ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store for wedding ... its latest collection of wedding dresses , and launches a ... the wedding dress on your big day; the wedding gown ... bride wants to find the most suitable wedding dress. Now, ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... Aug. 15 ( http://www.amdl.com ),AMDL Inc. (Amex: ... pharmaceuticals with,operations in Shenzhen, Jiangxi and Jilin China, ... chief financial officer Akio Ariura will,host a teleconference ... The call is scheduled for Tuesday, August 19, ...
... Neuroblastoma is one of the most devastating diagnoses a ... old when the disease is detected, most often by ... By then, the disease has often reached an advanced ... of the children in whom it develops, despite aggressive ...
... a,statement of Betsy Ryan, President and CEO, New ... today submitted an application to the,state to convert ... for-profit,company., All New Jerseyans should be concerned ... 2.9 million members, Horizon is the largest,provider of ...
... Aug. 15 The Hereditary Disease Foundation,(HDF) is ... has,approved Xenazine, or tetrabenazine, for the treatment of ... major cause of disability and death in patients ... inconvenience; it can,prevent Huntington,s disease patients from walking, ...
... Organizations Come Together to Promote Health Care Reform as the ... Priority for the Next President and Congress, WASHINGTON, Aug. ... to defeat health care reform in 1993-1994, will be back ... top of the,agenda., Airing throughout the Democratic and Republican ...
... spent more than a few sleepless nights, you,re not ... over 55 -- but you may also be at ... older adults don,t get enough restorative sleep, leading to ... problems and increased rates of depression. Unfortunately, current sleeping ...
Cached Medicine News:Health News:AMDL Announces Teleconference to Discuss Its Second Quarter 2008 Financial Results 2Health News:Experiments could lead to new treatments for neuroblastoma 2Health News:Experiments could lead to new treatments for neuroblastoma 3Health News:NJHA Raises Questions Regarding Horizon's Proposal to Convert to For-Profit Health Insurer 2Health News:'Harry and Louise' Icons Return To Promote Health Care Reform In New Ad 2Health News:A therapy for baby boomers to sleep on 2
... Traditionally, when choosing a non-contact diagnostic lens, ... wide field of view and high magnification. ... introduced by Volk Optical, doctors can have both ... widest field of view available in a non-contact ...
... is a 3.0mm single loaded suture anchor ... anchor barb catches on the cancellous bone ... "breaks" free. The small size is perfect ... used in rotator cuff repair where single ...
... Tac™ implantThe USS Sports Medicine™ E-Z Tac implant ... soft tissue to bone. The resorbable repair device ... bone and is used to reattach damaged soft ... a resorbable copolymer, a polyester derivative of lactic ...
... Soft Tissue Anchor 2 mm is a resorbable ... bone using sutures. The resorbable repair device is ... and is used to reattach damaged soft tissue. ... copolymer, derived from glycolide and lactide colored with ...
Medicine Products: